These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


292 related items for PubMed ID: 19117094

  • 1. Minimum FGF2 binding structural requirements of heparin and heparan sulfate oligosaccharides as determined by NMR spectroscopy.
    Guglier S, Hricovíni M, Raman R, Polito L, Torri G, Casu B, Sasisekharan R, Guerrini M.
    Biochemistry; 2008 Dec 30; 47(52):13862-9. PubMed ID: 19117094
    [Abstract] [Full Text] [Related]

  • 2. Dynamic properties of biologically active synthetic heparin-like hexasaccharides.
    Angulo J, Hricovíni M, Gairi M, Guerrini M, de Paz JL, Ojeda R, Martín-Lomas M, Nieto PM.
    Glycobiology; 2005 Oct 30; 15(10):1008-15. PubMed ID: 15958415
    [Abstract] [Full Text] [Related]

  • 3. Conformational transitions induced in heparin octasaccharides by binding with antithrombin III.
    Guerrini M, Guglieri S, Beccati D, Torri G, Viskov C, Mourier P.
    Biochem J; 2006 Oct 15; 399(2):191-8. PubMed ID: 16796563
    [Abstract] [Full Text] [Related]

  • 4. Biosynthetic oligosaccharide libraries for identification of protein-binding heparan sulfate motifs. Exploring the structural diversity by screening for fibroblast growth factor (FGF)1 and FGF2 binding.
    Jemth P, Kreuger J, Kusche-Gullberg M, Sturiale L, Giménez-Gallego G, Lindahl U.
    J Biol Chem; 2002 Aug 23; 277(34):30567-73. PubMed ID: 12058038
    [Abstract] [Full Text] [Related]

  • 5. Interaction of heparins with fibroblast growth factors: conformational aspects.
    Guerrini M, Hricovíni M, Torri G.
    Curr Pharm Des; 2007 Aug 23; 13(20):2045-56. PubMed ID: 17627538
    [Abstract] [Full Text] [Related]

  • 6. Structure of heparin-derived tetrasaccharide complexed to the plasma protein antithrombin derived from NOEs, J-couplings and chemical shifts.
    Hricovíni M, Guerrini M, Bisio A.
    Eur J Biochem; 1999 May 23; 261(3):789-801. PubMed ID: 10215897
    [Abstract] [Full Text] [Related]

  • 7. Structural specificity of heparin binding in the fibroblast growth factor family of proteins.
    Raman R, Venkataraman G, Ernst S, Sasisekharan V, Sasisekharan R.
    Proc Natl Acad Sci U S A; 2003 Mar 04; 100(5):2357-62. PubMed ID: 12604799
    [Abstract] [Full Text] [Related]

  • 8. Minimal heparin/heparan sulfate sequences for binding to fibroblast growth factor-1.
    Guerrini M, Agulles T, Bisio A, Hricovini M, Lay L, Naggi A, Poletti L, Sturiale L, Torri G, Casu B.
    Biochem Biophys Res Commun; 2002 Mar 22; 292(1):222-30. PubMed ID: 11890696
    [Abstract] [Full Text] [Related]

  • 9. Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.
    Loo BM, Kreuger J, Jalkanen M, Lindahl U, Salmivirta M.
    J Biol Chem; 2001 May 18; 276(20):16868-76. PubMed ID: 11278860
    [Abstract] [Full Text] [Related]

  • 10. Heparan sulfate domain organization and sulfation modulate FGF-induced cell signaling.
    Jastrebova N, Vanwildemeersch M, Lindahl U, Spillmann D.
    J Biol Chem; 2010 Aug 27; 285(35):26842-26851. PubMed ID: 20576609
    [Abstract] [Full Text] [Related]

  • 11. Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor.
    Moy FJ, Safran M, Seddon AP, Kitchen D, Böhlen P, Aviezer D, Yayon A, Powers R.
    Biochemistry; 1997 Apr 22; 36(16):4782-91. PubMed ID: 9125499
    [Abstract] [Full Text] [Related]

  • 12. Heparan sulfate-related oligosaccharides in ternary complex formation with fibroblast growth factors 1 and 2 and their receptors.
    Jastrebova N, Vanwildemeersch M, Rapraeger AC, Giménez-Gallego G, Lindahl U, Spillmann D.
    J Biol Chem; 2006 Sep 15; 281(37):26884-92. PubMed ID: 16807244
    [Abstract] [Full Text] [Related]

  • 13. Heparin/Heparan sulfate domains in binding and signaling of fibroblast growth factor 8b.
    Loo BM, Salmivirta M.
    J Biol Chem; 2002 Sep 06; 277(36):32616-23. PubMed ID: 12077148
    [Abstract] [Full Text] [Related]

  • 14. Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer.
    Casu B, Naggi A, Torri G.
    Matrix Biol; 2010 Jul 06; 29(6):442-52. PubMed ID: 20416374
    [Abstract] [Full Text] [Related]

  • 15. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
    Aviezer D, Levy E, Safran M, Svahn C, Buddecke E, Schmidt A, David G, Vlodavsky I, Yayon A.
    J Biol Chem; 1994 Jan 07; 269(1):114-21. PubMed ID: 8276782
    [Abstract] [Full Text] [Related]

  • 16. Generation of a specific immunological response to FGF-2 does not affect wound healing or reproduction.
    Plum SM, Vu HA, Mercer B, Fogler WE, Fortier AH.
    Immunopharmacol Immunotoxicol; 2004 Feb 07; 26(1):29-41. PubMed ID: 15106730
    [Abstract] [Full Text] [Related]

  • 17. Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library.
    Ashikari-Hada S, Habuchi H, Kariya Y, Itoh N, Reddi AH, Kimata K.
    J Biol Chem; 2004 Mar 26; 279(13):12346-54. PubMed ID: 14707131
    [Abstract] [Full Text] [Related]

  • 18. Highly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractions.
    Naimy H, Buczek-Thomas JA, Nugent MA, Leymarie N, Zaia J.
    J Biol Chem; 2011 Jun 03; 286(22):19311-9. PubMed ID: 21471211
    [Abstract] [Full Text] [Related]

  • 19. Biosynthesis of heparin/heparan sulfate. The D-glucosaminyl 3-O-sulfotransferase reaction: target and inhibitor saccharides.
    Razi N, Lindahl U.
    J Biol Chem; 1995 May 12; 270(19):11267-75. PubMed ID: 7744762
    [Abstract] [Full Text] [Related]

  • 20. Heparin/heparan sulfate N-sulfamidase from Flavobacterium heparinum: structural and biochemical investigation of catalytic nitrogen-sulfur bond cleavage.
    Myette JR, Soundararajan V, Behr J, Shriver Z, Raman R, Sasisekharan R.
    J Biol Chem; 2009 Dec 11; 284(50):35189-200. PubMed ID: 19726673
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.